pantethine and Coronary Disease

pantethine has been researched along with Coronary Disease in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	2 (66.67)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (33.33)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Azumano, I; Citrolo, D; Evans, M; Kamiya, T; Napolitano, JJ; Rumberger, JA	1
Abiko, Y; Shibano, T	1
Campanari, JC; Di Rienzo, F; Forti, N; Giannini, SD; Ziliotto, EE	1

Trials

2 trial(s) available for pantethine and Coronary Disease

Article	Year
Pantethine, a derivative of vitamin B5, favorably alters total, LDL and non-HDL cholesterol in low to moderate cardiovascular risk subjects eligible for statin therapy: a triple-blinded placebo and diet-controlled investigation. Vascular health and risk management, 2014, Volume: 10 Topics: Adult; Anticholesteremic Agents; Biomarkers; Cholesterol; Cholesterol, LDL; Combined Modality Therapy; Coronary Disease; Female; Florida; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Male; Middle Aged; Ontario; Pantetheine; Patient Selection; Practice Guidelines as Topic; Risk Assessment; Risk Factors; Time Factors; Treatment Outcome	2014
[Effects of pantethine on blood lipids]. Arquivos brasileiros de cardiologia, 1986, Volume: 46, Issue:4 Topics: Adult; Aged; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Clinical Trials as Topic; Coronary Disease; Female; Humans; Lipids; Male; Middle Aged; Pantetheine; Risk; Sulfhydryl Compounds; Triglycerides	1986

Article

Year

Pantethine, a derivative of vitamin B5, favorably alters total, LDL and non-HDL cholesterol in low to moderate cardiovascular risk subjects eligible for statin therapy: a triple-blinded placebo and diet-controlled investigation.

Vascular health and risk management, 2014, Volume: 10

Topics: Adult; Anticholesteremic Agents; Biomarkers; Cholesterol; Cholesterol, LDL; Combined Modality Therapy; Coronary Disease; Female; Florida; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Male; Middle Aged; Ontario; Pantetheine; Patient Selection; Practice Guidelines as Topic; Risk Assessment; Risk Factors; Time Factors; Treatment Outcome

2014

[Effects of pantethine on blood lipids].

Arquivos brasileiros de cardiologia, 1986, Volume: 46, Issue:4

Topics: Adult; Aged; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Clinical Trials as Topic; Coronary Disease; Female; Humans; Lipids; Male; Middle Aged; Pantetheine; Risk; Sulfhydryl Compounds; Triglycerides

1986

Other Studies

1 other study(ies) available for pantethine and Coronary Disease

Article	Year
Effect of pantethine on myocardial pH reduced by partial occlusion of the coronary artery in dogs with special reference to the myocardial levels of adenosine triphosphate, creatine phosphate, and lactate. Archives internationales de pharmacodynamie et de therapie, 1982, Volume: 255, Issue:2 Topics: Adenosine Triphosphate; Animals; Coronary Disease; Dogs; Female; Hemodynamics; Hydrogen-Ion Concentration; Lactates; Lactic Acid; Male; Myocardium; Oxygen Consumption; Pantetheine; Phosphocreatine; Sulfhydryl Compounds; Time Factors	1982

Article

Year

Effect of pantethine on myocardial pH reduced by partial occlusion of the coronary artery in dogs with special reference to the myocardial levels of adenosine triphosphate, creatine phosphate, and lactate.

Archives internationales de pharmacodynamie et de therapie, 1982, Volume: 255, Issue:2

Topics: Adenosine Triphosphate; Animals; Coronary Disease; Dogs; Female; Hemodynamics; Hydrogen-Ion Concentration; Lactates; Lactic Acid; Male; Myocardium; Oxygen Consumption; Pantetheine; Phosphocreatine; Sulfhydryl Compounds; Time Factors

1982